Scarica l'app Stockscreener
27.75
0.11%
-0.0286
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Baxter International Inc Borsa (BAX) Ultime notizie
Stifel raises Baxter stock price target on segment restructuring - Investing.com
Baxter issues recall of antibiotic IV bags after bits of cardboard flagged in solution - Fierce Pharma
UBS Adjusts Price Target on Baxter International to $25 From $19, Maintains Neutral Rating - marketscreener.com
Stifel Adjusts Price Target on Baxter International to $24 From $19, Maintains Hold Rating - marketscreener.com
Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX) and Baxter International (BAX) - The Globe and Mail
Why Baxter (BAX) Stock Is Up Today - Yahoo Finance
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION - Solomon's Words for the Wise
Baxter International Inc (BAX) Shares Surge 4.2% -- What GF Scor - GuruFocus
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International Inc (BAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Baxter International Q2 2026 Earnings Preview — July 30, Street Expects $0.37 EPS - AlphaStreet
TD Cowen Adjusts Price Target on Baxter International to $24 From $20, Maintains Hold Rating - Moomoo
BAX|Baxter International Inc|Price:23.335|Chg%:+0.935 - TradingKey
Baxter International Inc (BAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Baxter International Inc (BAX) Cash Flow - TradingKey
Baxter International Inc (BAX) Income Statement - TradingKey
Baxter International Inc (BAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Baxter International Inc (BAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Baxter International Inc (BAX) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Bank of New York Mellon Corp Reduces Holdings in Baxter International Inc. $BAX - MarketBeat
A Look at Baxter International Inc (BAX) After 3.4% Gain -- GF V - GuruFocus
Will Baxter's Q2 Results Continue to Reflect Operational Headwinds? - Yahoo Finance
Baxter stock trades steadily as spin-off and transformation reshape earnings profile - AD HOC NEWS
Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline - Yahoo Finance
Baxter International (BAX) Projected to Release Earnings on Thursday - MarketBeat
Baxter International stock trades steadily as spin-off plans follow mixed 2023 results - Ad-hoc-news.de
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
How Investors May Respond To Baxter (BAX) Class I VOLARA Recall And Quality Control Scrutiny - Sahm
Baxter stock trades steady as spin-off and portfolio reshaping shift focus toward margins - Ad-hoc-news.de
Baxter International stock trades steadily as core therapies support earnings and spin-off integrati - Ad-hoc-news.de
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter stock remains supported by its latest reported results - Ad-hoc-news.de
Baxter International stock trades steadily as spin-off and cost actions reshape earnings profile - Ad-hoc-news.de
Baxter International stock trades steady as spin-off of kidney care business and margin focus shape - Ad-hoc-news.de
Baxter: The Chart Points Higher, Valuation And Growth Are Less Appealing - Seeking Alpha
Baxter International Appoints Michael Lemberger as Director of People Analytics - hrtoday.in
Baxter International stock trades steadily as spin-off and portfolio reshaping reshape earnings prof - Ad-hoc-news.de
Baxter International (BAX) Q4 2024 earnings summary - Quartr
Is Baxter International Inc (BAX) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter stock trades steady as spin-off and earnings reshape the profile - Ad-hoc-news.de
Sumitomo Mitsui Trust Group Inc. Cuts Holdings in Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. (NYSE:BAX) Given Average Rating of "Reduce" by Analysts - MarketBeat
Baxter International Inc. Stock Climbs 5.4%, Outperforms Peers - webull.com
Baxter International's Q2 2026 earnings: What to expect - MSN
Baxter stock holds steady as restructuring and spin-off reshape the portfolio - Ad-hoc-news.de
Is Baxter’s Class I Respiratory Device Recall Reshaping the Investment Case for Baxter International (BAX)? - Sahm
Baxter International Updates Segment Reporting Structure and Metrics - The Globe and Mail
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - Stock Traders Daily
Q2 EPS Forecast for Baxter International Lowered by Analyst - MarketBeat
Baxter International (BAX) Announces Recast of Financial Reporti - GuruFocus
A Look at Baxter International Inc (BAX) After 3.4% Decline -- G - GuruFocus
Supply Chain Innovation Delivers More Nimble, Efficient Solutions - Baxter
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter reorganizes to two segments, recasts prior-period segment results and discloses operational/organic sales metrics - TradingView
Baxter (NYSE: BAX) recasts 2025 segment sales and shows $505M loss - Stock Titan
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $19, Maintains Neutral Rating - Moomoo
ETFs Investing in Baxter International Inc. Stocks - TradingView
Baxter stock reflects a diversified medical technology business - ad-hoc-news.de
Baxter International stock reflects a diversified medical portfolio and ongoing portfolio transforma - ad-hoc-news.de
Baxter International Inc. (BAX) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Press Release: Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors - Moomoo
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors - Business Wire
Retia Medical Adds Former Baxter Executive Christopher Benassi to Advisory Board - citybiz
Baxter International Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh - TradingView
0.65%
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):